Outcomes of Babies with Opioid Exposure -- Cincinnati site renewal
Project Number2UG1HD104254-02
Former Number1RL1HD104254-01
Contact PI/Project LeaderMERHAR, STEPHANIE L
Awardee OrganizationCINCINNATI CHILDRENS HOSP MED CTR
Description
Abstract Text
PROJECT SUMMARY/ABSTRACT
Limited data are available on the effects of antenatal opioid exposure on the brain and neurodevelopment.
Most studies are limited by methodologic flaws in study design, including small sample sizes and difficulty
controlling for important environmental variables. The OBOE (Outcomes of Babies with Opioid Exposure)
study, an ongoing NICHD-funded longitudinal study enrolling infants with and without antenatal opioid
exposure at birth and following them to 2 years of age, attempts to improve on the limitations of previous
research by collecting comprehensive exposure data including infant umbilical cords, advanced neuroimaging
data to evaluate brain development, and standardized and thorough information on the home environment,
maternal mental health, and parenting. The OBOE consortium, comprised of 4 highly performing centers, a
data coordinating center, and a neuroimaging core, has completed our goal enrollment of 200 opioid-exposed
and 100 unexposed infants. In response to RFA-HD-24-014, we now propose to complete follow-up to age two
in our OBOE cohort, to fulfill our main study objectives. The Cincinnati site has contributed to the OBOE
study by enrolling 149 infants (94 exposed and 55 controls), completing 233 MRIs thus far, and
contributing to the publication of multiple abstracts and three manuscripts using OBOE data. For this
renewal grant, we will continue progress toward our aims to: 1) determine the impact of antenatal opioid
exposure on brain structure and connectivity over the first two years of life; 2) define medical, developmental,
and behavioral trajectories over the first two years of life in exposed infants; and 3) determine how the home
environment, maternal mental health, and parenting modify trajectories of brain connectivity and
neurodevelopment over the first two years of life. Our progress so far, with enrollment completed and success
in following this difficult population, shows that we have the ability to successfully complete the objectives of
the OBOE study.
Public Health Relevance Statement
PROJECT NARRATIVE
Children exposed to opioids antenatally can have behavioral problems, lower school achievement, and
changes seen on brain MRI scans compared to unexposed children. In this multicenter study, Cincinnati is one
of four centers enrolling a total of 200 exposed infants and 100 unexposed controls. We will follow this cohort
to age 2 to evaluate brain structure and function, examine development and behavior, and determine the
relative effects of opioid exposure versus other environmental factors on outcomes.
NIH Spending Category
No NIH Spending Category available.
Project Terms
2 year oldAchievementAgeAreaBehaviorBehavioralBirthBrainCerebrumCertificationChildChild RearingChildhoodClinical ResearchCollaborationsDataData Coordinating CenterDevelopmentDiffusion Magnetic Resonance ImagingEnrollmentEnvironmentEnvironmental Risk FactorExposure toFundingGoalsGrantHealthcareHome environmentImpairmentInfantInfrastructureInternationalLifeLongitudinal StudiesMRI ScansMagnetic Resonance ImagingManuscriptsMeasuresMedicalMental HealthMethodologyMothersMulticenter Neonatal Research NetworkMulticenter StudiesNational Institute of Child Health and Human DevelopmentNeonatalNewborn InfantOpioidOutcomePatient Self-ReportPopulationPregnancyProblem behaviorProcessProductivityPsychotropic DrugsPublicationsPublishingQuestionnairesResearchResearch DesignRestSample SizeSchoolsSiteStandardizationStructureSurfaceTissuesTrainingUmbilical cord structureVisitantenatalanxiety symptomsbrain magnetic resonance imagingbrain volumeclinical centerclinical research sitecohortconnectomedepressive symptomsexperiencefetal opioid exposurefollow-upgray matterhigh risk infantimprovedmarijuana useneurodevelopmentneuroimagingnicotine useopioid exposureopioid useparticipant retentionpostnatalresponsesocial stigmasuccesswhite matter injury
Eunice Kennedy Shriver National Institute of Child Health and Human Development
CFDA Code
865
DUNS Number
071284913
UEI
JZD1HLM2ZU83
Project Start Date
01-October-2019
Project End Date
30-June-2027
Budget Start Date
29-July-2024
Budget End Date
30-June-2025
Project Funding Information for 2024
Total Funding
$160,500
Direct Costs
$100,000
Indirect Costs
$60,500
Year
Funding IC
FY Total Cost by IC
2024
National Institute on Drug Abuse
$160,500
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 2UG1HD104254-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 2UG1HD104254-02
Patents
No Patents information available for 2UG1HD104254-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 2UG1HD104254-02
Clinical Studies
No Clinical Studies information available for 2UG1HD104254-02
News and More
Related News Releases
No news release information available for 2UG1HD104254-02
History
No Historical information available for 2UG1HD104254-02
Similar Projects
No Similar Projects information available for 2UG1HD104254-02